China's biological influenza virus split vaccine has passed pre certification by the World Health Organization
Chinese Biology20231020Chinese BiologyWHOChinese BiologyChinese BiologyThe influenza virus split vaccine produced by Changchun Institute of Biological Products has officially launched the pre certification work of the World Health Organization since 2015, and has undergone comprehensive and in-depth benchmarking with the latest international regulations and guidelines. After process changes and continuous optimization, the product quality standards have been continuously improved...
The first export of tetravalent influenza vaccine from Wuhan Institute of Biological Products of China to Africa
On the morning of October 19th, the first batch of tetravalent influenza virus split vaccine exported to Africa by China Biological Wuhan Institute of Biological Products was sent to Kenya. This vaccine is the first influenza vaccine registered in Kenya and exported for sale by China National Pharmaceutical Group's China Biotechnology...
The Gates Foundation announced its support for the launch of phase III clinical trial of tuberculosis candidate vaccine
On June 28, the Wellcome Trust and the Bill and Melinda French Gates Foundation announced that they would provide funds to support the phase III clinical trial of tuberculosis candidate vaccine M72/AS01E (M72). If proved effective, M72 is expected to become the first new vaccine to prevent tuberculosis since the BCG vaccine vaccine was introduced in 1921...